Simonetto M, Rutrick S, LeMoss NM, Lansdale KN, Tagawa ST, Kamel H, Parikh N, Navi BB.
2022.
Adherence to Guideline-Recommended Cancer Screening in Stroke Survivors: A Nationwide Analysis.. J Stroke Cerebrovasc Dis. 31(3):106297.
Cho J, Nguyen TD, Huang W, Sweeney EM, Luo X, Kovanlikaya I, Zhang S, Gillen KM, Spincemaille P, Gupta A et al..
2022.
Brain oxygen extraction fraction mapping in patients with multiple sclerosis.. J Cereb Blood Flow Metab. 42(2):338-348.
Longbrake EE, Hua LH, Mowry EM, Gauthier SA, Alvarez E, Cross AH, Pei J, Priest J, Raposo C, Hafler DA et al..
2022.
The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome.. Mult Scler Relat Disord. 68:104143.
De Michele M, Kahan J, Berto I, Schiavo OG, Iacobucci M, Toni D, Merkler AE.
2022.
Cerebrovascular Complications of COVID-19 and COVID-19 Vaccination.. Circ Res. 130(8):1187-1203.
Zinger N, Ponath G, Sweeney E, Nguyen TD, Lo CHung, Diaz I, Dimov A, Teng L, Zexter L, Comunale J et al..
2022.
Dimethyl Fumarate Reduces Inflammation in Chronic Active Multiple Sclerosis Lesions.. Neurol Neuroimmunol Neuroinflamm. 9(2)